1. Home
  2. WVE vs TRMK Comparison

WVE vs TRMK Comparison

Compare WVE & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.07

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Trustmark Corporation

TRMK

Trustmark Corporation

HOLD

Current Price

$44.21

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
TRMK
Founded
2012
1889
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
WVE
TRMK
Price
$7.07
$44.21
Analyst Decision
Strong Buy
Hold
Analyst Count
16
2
Target Price
$29.81
$44.50
AVG Volume (30 Days)
3.9M
298.8K
Earning Date
04-28-2026
04-28-2026
Dividend Yield
N/A
2.26%
EPS Growth
N/A
1.93
EPS
N/A
0.95
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$9.82
Revenue Next Year
$85.67
$4.86
P/E Ratio
N/A
$47.11
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$33.39
52 Week High
$21.73
$45.99

Technical Indicators

Market Signals
Indicator
WVE
TRMK
Relative Strength Index (RSI) 39.03 47.84
Support Level $6.81 $43.45
Resistance Level $7.67 $45.54
Average True Range (ATR) 0.36 0.94
MACD 0.15 -0.13
Stochastic Oscillator 28.00 19.50

Price Performance

Historical Comparison
WVE
TRMK

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About TRMK Trustmark Corporation

Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.

Share on Social Networks: